Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Transplantation and Cellular Therapy|June 21, 2025
Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host DiseaseVictoria Brehm, Ziyi Wang, Luis Rocha, et al.
Open Forum Infectious Diseases|May 9, 2019
Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot StudyJessica R Galloway-Peña, Christine B Peterson, Farida Malik, et al.
Science Translational Medicine|June 14, 2023
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitisTaylor M Halsey, Anusha S Thomas, Tomo Hayase, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Nature Medicine|April 11, 2018
Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.
Cancer Immunology Research|February 16, 2024
Tsyn-Seq: a T-cell Synapse-Based Antigen Identification PlatformYimei Jin, Takahiko Miyama, Alexandria Brown, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Nature Medicine|January 9, 2018
Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.
Pageof 14